Ledipasvir / Sofosbuvir


( Last Updated : September 15, 2014)
Generic Name:
Ledipasvir / Sofosbuvir
Project Status:
Complete
Therapeutic Area:
Hepatitis C, chronic
Manufacturer:
Gilead Sciences Canada Inc.
Call for patient/clinician input open:
Brand Name:
Harvoni
Project Line:
Reimbursement Review
Project Number:
SR0395-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Submission Type:
Initial
Indications:
Hepatitis C, chronic
Recommendation Type:
List with criteria/condition
Final Recommendation: